Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine
$5.12 +0.39% Close, 9 Oct 2026
Price $5.12 −22.19% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 Mar 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue2,451.6Operating income254.6Net income−85.6EPS, diluted−1.95Fiscal year 2023Revenue3,875.9 +58.1%Operating income560.3Net income−253.9EPS, diluted−5.78Fiscal year 2024Revenue4,386.1 +13.2%Operating income783.8Net income110.3EPS, diluted1.63
FY2022FY2023FY2024
Revenue 2,451.6 3,875.9 4,386.1
Growth +58.1% +13.2%
Operating income 254.6 560.3 783.8
Net income −85.6 −253.9 110.3
Growth
EPS, diluted −1.95 −5.78 1.63

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin35.9%Operating margin10.4%Net margin−3.5%Free cash flow margin2.5%Fiscal year 2023Gross margin37.0%Operating margin14.5%Net margin−6.6%Free cash flow margin12.0%Fiscal year 2024Gross margin39.3%Operating margin17.9%Net margin2.5%Free cash flow margin13.2%
FY2022FY2023FY2024
Gross margin 35.9% 37.0% 39.3%
Operating margin 10.4% 14.5% 17.9%
Net margin −3.5% −6.6% 2.5%
Free cash flow margin 2.5% 12.0% 13.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow162.6Capital expenditure−102.5Free cash flow60.1Dividends paid−0.1Fiscal year 2023Operating cash flow582.4Capital expenditure−116.2Free cash flow466.2 +675.1%Dividends paid−6.8Fiscal year 2024Operating cash flow668.5Capital expenditure−90.9Free cash flow577.6 +23.9%Dividends paid−1.2
FY2022FY2023FY2024
Operating cash flow 162.6 582.4 668.5
Capital expenditure −102.5 −116.2 −90.9
Free cash flow 60.1 466.2 577.6
Growth +675.1% +23.9%
Dividends paid −0.1 −6.8 −1.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Cash208.7Total debt1,307.7Net cash (debt)−1,099.0Shareholders’ equity1,065.0Debt to equity1.23Fiscal year 2023Cash241.1Total debt3,376.3Net cash (debt)−3,135.1Shareholders’ equity1,465.3Debt to equity2.30Fiscal year 2024Cash235.7Total debt2,965.5Net cash (debt)−2,729.8Shareholders’ equity1,477.2Debt to equity2.01
FY2022FY2023FY2024
Cash 208.7 241.1 235.7
Total debt 1,307.7 3,376.3 2,965.5
Net cash (debt) −1,099.0 −3,135.1 −2,729.8
Shareholders’ equity 1,065.0 1,465.3 1,477.2
Debt to equity 1.23 2.30 2.01

In millions of PEN, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Income statement

In millions of PEN, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024
Revenue and profit
2,451.6 3,875.9 4,386.1
Growth +58.1% +13.2%
1,571.9 2,440.6 2,660.8
879.7 1,435.3 1,725.3
Growth +63.2% +20.2%
254.6 560.3 783.8
Growth +120.1% +39.9%
−47.4 −124.2 183.8
29.4 90.2 59.8
−85.6 −253.9 110.3
Growth
Per share
−1.95 −5.78 1.64
−1.95 −5.78 1.63
Growth
43.9 43.9 67.3
43.9 43.9 67.5
Growth +0.0% +53.7%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in PEN as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 3 years on file.